Zika treatment News
The Zika flavivirus that broke out as an epidemic in Brazil in 2015 and spread to 70 countries in the world, also made an appearance in India in late May this year.
The team's protein-based vaccine uses the smallest and most unique part of the Zika virus that can still elicit a potent and robust immune response.
Tests confirmed the compounds halted the virus and stopped it from replicating without damage to host mammalian cells, researchers said.
The flavivirus is known to be carried by an infected Aedes species mosquito (Ae. aegypti and Ae. Albopictus) that are also responsible for the transmission of dengue and chikungunya viruses.
Rapid and promising progress has been made towards Zika vaccines, but they have been made either from an inactivated version of the Zika virus or subunits of the virus.
Loading...